Pei Liu

ORCID: 0009-0003-2434-7164 · 3 papers in corpus
review 2026
Nanotechnology in reproductive medicine: from gamete engineering to precision therapeutics
RSC advances ·doi:10.1039/d6ra01614f

Infertility represents a significant global health burden, necessitating advanced therapeutic interventions. While Assisted Reproductive Technologies have revolutionized fertility treatment, they remain constrained by limited efficacy, off-…

rct 2024
P2X3 Receptor Antagonist Eliapixant in Phase I Clinical Trials: Safety and Inter-ethnic Comparison of Pharmacokinetics in Healthy Chinese and Japanese Participants
Clinical pharmacokinetics ·doi:10.1007/s40262-024-01387-y

BACKGROUND: Afferent neuronal hypersensitization via P2X3 receptor signaling has been implicated as a driver of several disorders, including refractory chronic cough, endometriosis, diabetic neuropathic pain, and overactive bladder. Eliapix…

article 2021
17β-estradiol promotes angiogenesis through non-genomic activation of Smad1 signaling in endometriosis
Vascular pharmacology ·doi:10.1016/j.vph.2021.106932

17β-estradiol (E2) plays a key role in endometriosis through regulation of angiogenesis. Smad1 has been reported to be up-regulated in patients with endometriosis. However, the role of Smad1 in E2-mediated angiogenesis during the developmen…